Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727725 · ClinicalTrials.gov registry record · NA
An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02727725 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants.
The verdict
NCT02727725, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
* The purpose of this study is to show that the novel TRAMINER (T(Rho) and Magnetization Transfer and Inversion Recovery) sequence provides at least as good visualization and detection of sub-endocardial scarring, fibrosis, and acute infarction as the current gold standard Inversion Recovery (IR) Turbo-Flash sequence. * The hypothesis is that the TRAMINER sequence has the same or higher sensitivity in detecting small sub-endocardial scarring than the inversion recovery segmented gradient echo sequence known as IR-Turbo Fast low angle shot (IR Turbo-Flash), which is the accepted current gold standard for the detection of myocardial viability.
Interventions
- OTHER Traminer MRI Sequence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-01-15 |
| Est. Completion | 2018-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02727725
The ClinicalTrials.gov registry entry for NCT02727725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Traminer MRI Sequence is the first listed.
NCT02727725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02727725 about?
NCT02727725 is a clinical study titled "An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images". * The purpose of this study is to show that the novel TRAMINER (T(Rho) and Magnetization Transfer and Inversion Recovery) sequence provides at least as good visualization and detection of sub-endocardial scarring, fibrosis, and acute infarction as the current gold standard Inversion Recovery (IR) Tu...
What is the current status of trial NCT02727725?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2016-01-15. Estimated completion is 2018-01-15.
What interventions are being tested in trial NCT02727725?
The interventions under investigation include: Traminer MRI Sequence (OTHER).
Who is sponsoring clinical trial NCT02727725?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.